Diagnosis and treatment of renal artery stenosis

Nature Reviews Nephrology

Volumn 6, Issue 3, 2010, Pages 151-159

  Plouin, Pierre François ^a   Bax, Liesbeth ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; STATIN;

ANGIOPLASTY; ARTERITIS; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONVENTIONAL ANGIOGRAPHY; DISEASE COURSE; ECHOGRAPHY; FIBROMUSCULAR DYSPLASIA; HEREDITY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INCIDENCE; INVASIVE PROCEDURE; KIDNEY ARTERY STENOSIS; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY SURGERY; MAGNETIC RESONANCE ANGIOGRAPHY; MUSCLE DISEASE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RARE DISEASE; RENAL ARTERY; RENOGRAPHY; REVASCULARIZATION; REVIEW; RISK FACTOR; SCREENING; STENT; TREATMENT OUTCOME;

ANGIOPLASTY; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; BALLOON DILATATION; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PATIENT SELECTION; PROGNOSIS; RENAL ARTERY OBSTRUCTION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STENTS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; VASODILATOR AGENTS;

EID: 77649187834     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2009.230     Document Type: Review

References (67)

1. safian, R. D. & Textor, S. C. Renal-artery stenosis. N. Engl. J. Med. 344, 431-442 (2001).
2. Rundback, J. H. et al. Guidelines for the reporting of renal artery revascularization in clinical trials. Circulation 106, 1572-1585 (2002).
3. Hirsch, A. T. et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation 113, e463-e654 (2006).
4. de Mast, Q. & Beutler, J. J. The prevalence of atherosclerotic renal artery stenosis in risk groups: a systematic literature review. J. Hypertens. 27, 1333-1340 (2009).
5. De Bruyne, B. et al. Assessment of renal artery stenosis severity by pressure gradient measurements. J. Am. Coll. Cardiol. 48, 1851-1855 (2006).
6. Drieghe, B. et al. Assessment of renal artery stenosis: side-by-side comparison of angiography and duplex ultrasound with pressure gradient measurements. Eur. Heart J. 29, 517-524 (2008).
7. van de ven, P. J. et al. Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease. Kidney Int. 53, 986-993 (1998).
8. Caps, M. T. et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 98, 2866-2872 (1998).
9. Rocha-sing, K. J. et al. Atherosclerotic peripheral vascular disease symposium ii: intervention for renal artery disease. Circulation 118, 2873-2878 (2008).
10. slovut, D. P. & Olin, J. W. Fibromuscular dysplasia. N. Engl. J. Med. 350, 1862-1871 (2004).
11. Plouin, P. F. et al. Fibromuscular dysplasia. Orphanet J. Rare Dis. 2, 28 (2007).
12. Tullus, K. et al. Renovascular hypertension in children. Lancet 371, 1453-1463 (2008).
13. Hansen, K. J. et al. Prevalence of renovascular disease in the elderly: a population-based study. J. Vasc. Surg. 36, 443-451 (2002).
14. Edwards, M. S., Craven, T. E., Burke, G. L., Dean, R. H. & Hansen, K. J. Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Arch. Intern. Med. 165, 207-213 (2005).
15. Axelrod, D. A. et al. Percutaneous stenting of incidental unilateral renal artery stenosis: decision analysis of costs and benefits. J. Endovasc. Ther. 10, 546-556 (2003).
16. Cheung, C. M. et al. The effects of statins on the progression of atherosclerotic renovascular disease. Nephron Clin. Pract. 107, c35-c42 (2007).
17. Pearce, J. D. et al. Progression of atheroscleroti renovascular disease: A prospective population-based study. J. Vasc. Surg. 44, 955-962 (2006).
18. Farmer, C. K., Cook, G. J., Blake, G. M., Reidy, J. & scoble, J. E. individual kidney function in atherosclerotic nephropathy is not related to the presence of renal artery stenosis. Nephrol. Dial. Transplant. 14, 2880-2884 (1999).
19. suresh, M., Laboi, P., Mamtora, H. & Kalra, P. A. Relationship of renal dysfunction to proximal arterial disease severity in atherosclerotic renovascular disease. Nephrol. Dial. Transplant. 15, 631-636 (2000).
20. Cheung, C. M. et al. Epidemiology of renal dysfunction and patient outcome in atherosclerotic renal artery occlusion. J. Am. Soc. Nephrol. 13, 149-157 (2002).
21. Wright, J. R. et al. A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am. J. Kidney Dis. 39, 1153-1161 (2002).
22. Meier, P., Rossert, J., Plouin, P. F. & Burnier, M. Atherosclerotic renovascular disease: beyond the renal artery stenosis. Nephrol. Dial. Transplant. 22, 1002-1006 (2007).
23. Textor, s. C., Lerman, L. & McKusick, M. The uncertain value of renal artery interventions: where are we now? JACC Cardiovasc. Interv. 2, 175-182 (2009).
24. Kalra, P. A. et al. Atherosclerotic renovascular disease in United states patients aged 67 years or older: risk factors, revascularization and prognosis. Kidney Int. 68, 293-301 (2005).
25. Hackam, D. G. et al. Angiotensin inhibition in renovascular disease: a population-based cohort study. Am. Heart J. 156, 549-555 (2008).
26. white, C. J. et al. indications for renal arteriography at the time of coronary arteriography. Circulation 114, 1892-1895 (2006).
27. Vasbinder, G. B. C. et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann. Intern. Med. 141, 674-682 (2004).
28. Huot, S. J., Hansson, J. H., Dey, H. & Concato, J. Utility of captopril renal scans for detecting renal artery stenosis. Arch. Intern. Med. 162, 1981-1984 (2002).
29. Leiner, T., de Haan, M. W., Nelemans, P. J., van Engelshoven, J. M. A. & Vasbinder, G. B. C. Contemporary imaging techniques for the diagnosis of renal artery stenosis. Eur. Radiol. 15, 2219-2229 (2005).
30. Plouin, P. F. et al. Restenosis after a first percutaneous transluminal renal angioplasty. Hypertension 21, 89-96 (1993).
31. van Jaarsveld, B. C. et al. inter-observer variability in the angiographic assessment of renal artery stenosis. J. Hypertens. 17, 1731-1736 (1999).
32. Leesar, M. A. et al. Prediction of hypertension improvement after stenting of renal artery stenosis: comparative accuracy of translesional pressure gradients, intravascular ultrasound, and angiography. J. Am. Coll. Cardiol. 53, 2363-2371 (2009).
33. Antithrombotic Trialists' Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373, 1849-1860 (2009).
34. Navaneethan, S. D. et al. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database of Systematic Reviews, issue 4. Art. No.: CD007784. doi:10.1002/14651858. CD007784 (2009).
35. Silva, V. S. et al. Pleiotropic effects of statins may improve outcomes in atherosclerotic renovascular disease. Am. J. Hypertens. 21, 1163-1168 (2008).
36. Hackam, D. G., Spence, J. D., Garg, A. X. & Textor, S. C. Role of renin-angiotensin system blockade in atherosclerotic renal artery stenosis and renovascular hypertension. Hypertension 50, 998-1003 (2007).
37. Miyamori, I. et al. Effects of converting enzyme inhibition on split renal function in renovascular hypertension. Hypertension 8, 415-421 (1986).
38. Franklin, S. S. & smith, R. D. Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension. Am. J. Med. 79, 14-23 (1985).
39. Losito, A. et al. Long-term follow-up of atherosclerotic renovascular disease. Beneficial effect of ACE inhibition. Nephrol. Dial. Transplant. 20, 1604-1609 (2005).
40. Uzzo, R. G., Novick, A. C., Goormastic, M., Mascha, E. & Pohl, M. Medical versus surgical management of atherosclerotic renal artery stenosis. Transplant Proc. 34, 723-725 (2002).
41. Weibull, H. et al. Percutaneous transluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J. Vasc. Surg. 18, 841-850 (1993).
42. Balzer, K. M. et al. Prospective randomized trial of operative vs interventional treatment for renalartery ostial occlusive disease (RAOOD). J. Vasc. Surg. 49, 667-674 (2009).
43. Ramsay, L. E. & waller, P. C. Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series. BMJ 300, 569-572 (1990).
44. Webster, J. et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish an Newcastle Renal Artery stenosis Collaborative Group. J. Hum. Hypertens. 12, 329-335 (1998).
45. Plouin, P. F., Chatellier, G., Darné, B. & Raynaud, A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) study Group. Hypertension 31, 823-829 (1998).
46. van Jaarsveld, B. C. et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery stenosis intervention Cooperative study Group. N. Engl. J. Med. 342, 1007-1014 (2000).
47. Nordmann, A. J., woo, K., Parkes, R. & Logan, A. G. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am. J. Med. 114, 44-50 (2003).
48. Bettmann, M. A. et al. Atherosclerotic vascular disease conference: writing Group VI: revascularization. Circulation 109, 2643-2650 (2004).
49. van de Ven, P. J. et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 353, 282-286 (1999).
50. Lekston, A. et al. Angiographic and intravascular ultrasound assessment of immediate and 9-month efficacy of percutaneous transluminal renal artery balloon angioplasty with subsequent brachytherapy in patients with renovascular hypertension. Kidney Blood Press. Res. 31, 291-298 (2008).
51. Radermacher, J. Resistive index: an ideal test for renovascular disease or ischemic nephropathy? Nat. Clin. Pract. Nephrol. 2, 232-233 (2006).
52. Chrysochou, C. et al. Proteinuria as a predictor of renal functional outcome after revascularization in atherosclerotic renovascular disease. QJM 102, 283-288 (2009).
53. Hiramoto, J. et al. Atheroemboli during renal artery angioplasty: an ex vivo study. J. Vasc. Surg. 41, 1026-1030 (2005).
54. Cooper, C. J. et al. Embolic protection and platelet inhibition during renal artery stenting. Circulation 117, 2752-2760 (2008).
55. Bax, L. et al. stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann. Intern. Med. 150, 840-848 (2009).
56. wheatley, K. et al. Revascularization versus medical therapy for renal-artery stenosis. N. Engl. J. Med. 361, 1953-1962 (2009).
57. Cooper, C. J. et al. stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: rationale and design of the CORAL trial. Am. Heart J. 152, 59-66 (2006).
58. Leertrouver, T. C. et al. stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology 216, 78-85 (2000).
59. Balk, E. et al. Effectiveness of management strategies for renal artery stenosis: a systematic review. Ann. Intern. Med. 145, 901-912 (2006).
60. Plouin, P. F. stable patients with atherosclerotic renal artery stenosis should be treated first with medical management. Am. J. Kidney Dis. 42, 851-857 (2003).
61. McCormack, L. J., Poutasse, E. F., Meaney, T. F., Noto, T. J. Jr & Dustan, H. P. A pathologic-arteriographic correlation of renal arterial disease. Am. Heart J. 72, 188-198 (1966).
62. Lassiter, F. D. The string-of-beads sign. Radiology 206, 437-438 (1998).
63. Fibromuscular dysplasia of arteries Online Mendelian Inheritance in Man® [online], http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=135580
64. Bigazzi, R., Bianchi, S., Quilici, N., salvadori, R. & Baldari, G. Bilateral fibromuscular dysplasia in identical twins. Am. J. Kidney Dis. 32, E4 (1998).
65. Pannier-Moreau, I. et al. Possible familial origin of multifocal renal artery fibromuscular dysplasia. J. Hypertens. 15, 1797-1801 (1997).
66. Boutouyrie, P. et al. Evidence for carotid and radial artery wall subclinical lesions in renal fibromuscular dysplasia. J. Hypertens. 21, 2287-2295 (2003).
67. Perdu, J. et al. inheritance of arterial lesions in renal fibromuscular dysplasia. J. Hum. Hypertens. 21, 393-400 (2007).